Literature DB >> 27086208

The longitudinal trends in the relationship between drug-induced extrapyramidal symptoms and personal and social performance in a population of the patients with schizophrenia: A latent growth model.

In-Jo Park1, Dong Chung Jung2, Samuel Suk-Hyun Hwang3, Hee Yeon Jung4, Jin-Sang Yoon5, Chul-Eung Kim6, Yong Min Ahn7, Yong Sik Kim8.   

Abstract

The aim of this study was to explore the longitudinal trends in the relationship between personal and social functioning and drug-induced extrapyramidal symptoms (DIEPS). The baseline sample included 484 patients with schizophrenia. Participants were assessed at baseline, weeks 4 (time 2), 8 (time 3), and 12 (time 4) regarding social functioning, and DIEPS. In latent growth analysis, the path coefficient between the intercept for the DIEPSS and the intercept for the PSP indicated a significant cross-sectional relationship between these two variables. And the path coefficient between the intercept of the DIEPSS and the slope of the PSP was also significant, indicating that patients who initially had more serious side effects tended to exhibit less improvement in their personal and social functioning over time. Similarly, a significant path coefficient between the slopes of the two variables indicated a dynamic and possibly reciprocal association over time. In addition, K-PSP scale showed good construct validity and reliability. Based on the standardized PSP scale, our results demonstrate DIEPSS induced by antipsychotic treatment dynamically affect personal and social functioning over time, a negative association between psychosocial aspects and the DIEPS.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Drug-induced extrapyramidal symptoms; Personal and social functioning; Quality of life; Schizophrenia

Mesh:

Substances:

Year:  2016        PMID: 27086208     DOI: 10.1016/j.psychres.2016.01.069

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  Drug-induced Extrapyramidal Symptoms Scale (DIEPSS) Serbian Language version: Inter-rater and Test-retest Reliability.

Authors:  Ami Peljto; Ljubica Zamurovic; Milica Pejovic Milovancevic; Branko Aleksic; Dusica Lecic Tosevski; Toshiya Inada
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

2.  Development and clinimetric assessment of a nurse-administered screening tool for movement disorders in psychosis.

Authors:  Bettina Balint; Helen Killaspy; Louise Marston; Thomas Barnes; Anna Latorre; Eileen Joyce; Caroline S Clarke; Rosa De Micco; Mark J Edwards; Roberto Erro; Thomas Foltynie; Rachael M Hunter; Fiona Nolan; Anette Schrag; Nick Freemantle; Yvonne Foreshaw; Nicholas Green; Kailash P Bhatia; Davide Martino
Journal:  BJPsych Open       Date:  2018-09-27

3.  Efficacy of low-dose D2/D3 partial agonist pramipexole on neuroleptic-induced extrapyramidal symptoms and symptoms of schizophrenia: a stage-1 open-label pilot study.

Authors:  Jia Jun Weng; Li Hua Wang; Hao Zhu; Wen Rong Xu; Yu Mei Wei; Zhi Yang Wang; Wen Juan Yu; Hua Fang Li
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-07       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.